These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Markers of pulmonary hypertension in potential candidates to heart transplantation. Wierzbicki K, Przybyłowski P, Sobczyk D, Konstanty J, Kapelak B, Drwiła R, Krochin M, Podolec P, Wójcik S, Marek G, Wróbel K, Piatek J, Rudziński P, Sadowski J. Przegl Lek; 2006 Oct 17; 63(12):1263-8. PubMed ID: 17642136 [Abstract] [Full Text] [Related]
26. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients. Khan TA, Schnickel G, Ross D, Bastani S, Laks H, Esmailian F, Marelli D, Beygui R, Shemin R, Watson L, Vartapetian I, Ardehali A. J Thorac Cardiovasc Surg; 2009 Dec 17; 138(6):1417-24. PubMed ID: 19931670 [Abstract] [Full Text] [Related]
27. [Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases]. Tian Z, Chen TB, Fang Q, Zeng XF, Liu YT, Li MT, Jiang XC, Gao P, Cheng KA, Wang Q. Zhonghua Yi Xue Za Zhi; 2009 Aug 11; 89(30):2099-102. PubMed ID: 20058611 [Abstract] [Full Text] [Related]
28. Inhaled iloprost controls pulmonary hypertension after cardiopulmonary bypass. Theodoraki K, Rellia P, Thanopoulos A, Tsourelis L, Zarkalis D, Sfyrakis P, Antoniou T. Can J Anaesth; 2002 Nov 11; 49(9):963-7. PubMed ID: 12419726 [Abstract] [Full Text] [Related]
29. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance. Sablotzki A, Hentschel T, Gruenig E, Schubert S, Friedrich I, Mühling J, Dehne MG, Czeslick E. Eur J Cardiothorac Surg; 2002 Nov 11; 22(5):746-52. PubMed ID: 12414041 [Abstract] [Full Text] [Related]
30. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease. Yin N, Kaestle S, Yin J, Hentschel T, Pries AR, Kuppe H, Kuebler WM. Crit Care Med; 2009 Mar 11; 37(3):980-6. PubMed ID: 19237907 [Abstract] [Full Text] [Related]
31. Nitric oxide in conjunction with milrinone better stabilized pulmonary hemodynamics after Fontan procedure. Cai J, Su Z, Shi Z, Zhou Y, Xu Z, Liu J, Chen L, Xu Z, Yu X, Ding W, Yang Y. Artif Organs; 2008 Nov 11; 32(11):864-9. PubMed ID: 18959679 [Abstract] [Full Text] [Related]
32. Managing pulmonary hypertension in heart transplantation: meeting the challenge. Coe PF. Crit Care Nurse; 2000 Apr 11; 20(2):22-8; quiz 29-30. PubMed ID: 11873750 [Abstract] [Full Text] [Related]
33. Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled aerosolized prostacyclin. Rocca GD, Coccia C, Pompei L, Ruberto F, Venuta F, De Giacomo T, Pietropaoli P. J Cardiothorac Vasc Anesth; 2001 Apr 11; 15(2):224-7. PubMed ID: 11312484 [Abstract] [Full Text] [Related]
39. A retrospective comparison of inhaled milrinone and iloprost in post-bypass pulmonary hypertension. Theodoraki K, Thanopoulos A, Rellia P, Leontiadis E, Zarkalis D, Perreas K, Antoniou T. Heart Vessels; 2017 Dec 11; 32(12):1488-1497. PubMed ID: 28717881 [Abstract] [Full Text] [Related]
40. [The pulmonary vasodilatory effect of inhaled prostacyclin and milrinone in heart]. Ricksten S. Rev Esp Anestesiol Reanim; 2001 Dec 11; 48(10):460-1. PubMed ID: 11792300 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]